RSS

Absorb

The US Food and Drug Administration (FDA) Advisory Committee gives Abbott’s fully dissolving heart stent a positive review and recommends the FDA approve it more

News

Abbott has announced positive one-year clinical results from the Absorb III trial more

News

Abbott has published data which the company says supports the long-term performance of its Absorb bioresorbable vascular stent. Absorb is a landmark device because it is the first fully bioresorbable stent which can be used in vascular settings. more

Devices